HENZO KENYA, is a community of about 700 Chronic Myeloid Leukemia (CML) and 300 Gastro-intestinal stromal tumors (GIST) patients, who are brought together by Glivec, (Imatinib) from Novartis that is made accessible to them free of charge through Max Foundation.
Our mission is to create awareness about CML, GIST and other Cancers, provide emotional and social support to members and other cancer patients and to do advocate for mainstreaming of issues related to cancer that affect patients and general public.
Henzo Kenya advocates for health concerns of CML and GIST cancer patients to be mainstreamed in relevant government and non-governmental agencies. Henzo Kenya actively engages various governmental and non-governmental departments to ensure consideration of cancer patients and their communities in planning and related health budgets. Strategic liaisons with similar organizations help to produce synergy in achieving these objectives.